COMMUNIQUÉS West-GlobeNewswire

Herantis Pharma Oyj: Manager’s Transactions - Inveni Life Sciences Fund I Ky
31/05/2019
Herantis Pharma Oyj: Manager’s Transactions - Inveni Life Sciences Fund I Ky Herantis Pharma Plc Company release 31 May 2019 at 1:00 pm Herantis Pharma Oyj - Managers' Transactions [...]
ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for ASLAN004 From CSL
31/05/2019
- Amending their previous agreement, CSL grants ASLAN full global rights to develop, manufacture and commercialise ASLAN004 SINGAPORE, May 31, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a [...]
Oncology Venture publishes Q1 report for 2019
31/05/2019
Company Announcement Hoersholm, Denmark – May 31, 2019 – Oncology Venture A/S (OV:ST) (“Oncology Venture”) today publishes the Interim Report for the first quarter of 2019. The Interim Report is available as an attached [...]
Kiadis Pharma raises c.EUR 28 million in a private placement of c.3.7 million new shares
31/05/2019
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release, publication or distribution [...]
Herantis Pharma Plc’s nomination of Vice Chairman
31/05/2019
Herantis Pharma Plc’s nomination of Vice Chairman Herantis Pharma Plc Company release 31 May 2019 at 8:00 AM The Board of Directors of Herantis Pharma Plc has nominated Timo Veromaa as its Vice Chairman. Further [...]
Innate Pharma announces publication in Cell on innovative multifunctional NKp46 NK cell engagers (NKCEs)
31/05/2019
The findings describe potential first-in-class NKp46 NKCEs, a new generation of multifunctional antibody-based molecules for fighting cancer The NKCE technology provides a versatile platform to generate formats that co- [...]
Innate Pharma annonce une publication dans Cell sur des anticorps multispecifiques innovants engageant les cellules NK via NKp46
31/05/2019
INNATE PHARMA ANNONCE UNE PUBLICATION DANS CELL SUR DES ANTICORPS MULTISPÉCIFIQUES INNOVANTS ENGAGEANT LES CELLULES NK VIA NKP46 Les recherches présentées mettent en évidence le potentiel des anticorps multispécifiques [...]
BrainStorm Presents Poster at Consortium of Multiple Sclerosis Centers (CMSC) 33rd Annual Meeting
31/05/2019
Design of Phase 2 Open-Label Multicenter Study in Progressive MS Outlined NEW YORK and SEATTLE, May 31, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. ( NASDAQ: BCLI ), a leader in developing innovative [...]
Bone Therapeutics to participate in upcoming conferences
31/05/2019
Press Release Gosselies, Belgium, 31 May 2019, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapeutics to [...]
Bone Therapeutics annonce sa participation à plusieurs évènements sectoriels
31/05/2019
Communiqué de presse Gosselies, Belgique, le 31 Mai 2019, 7h00 CEST – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux non [...]
Roche and GE Healthcare launch NAVIFY Tumor Board with medical imaging capabilities to enable more personalised treatment decisions in cancer care
31/05/2019
Roche and GE Healthcare launch NAVIFY Tumor Board with medical imaging capabilities to enable more personalised treatment decisions in cancer care Radiologists can now upload their patient records to the same dashboard [...]
Myovant Sciences Announces Pricing of $125 Million Public Offering of Common Shares
31/05/2019
BRISBANE, Calif. and BASEL, Switzerland, May 30, 2019 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) (“ Myovant ”), a clinical-stage healthcare company focused on developing and commercializing innovative therapies [...]
Amicus Therapeutics Prices Underwritten Offering of Common Stock
31/05/2019
CRANBURY, N.J., May 30, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced the pricing of an underwritten offering of 16,279,070 shares of its common stock at $10.75 per share. The gross [...]
Ascent Industries Provides Bi-Weekly Default Status Report
31/05/2019
VANCOUVER, British Columbia, May 30, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. ( CSE: ASNT ) (“ Ascent ” or the “ Company ”) is providing this bi-weekly default status report in accordance with National Policy 12 [...]
Mesoblast Reports Financial Results and Operational Highlights for the Period Ended March 31, 2019
31/05/2019
Major corporate milestone achieved in initiating BLA filing with FDA for Mesoblast’s cell therapy in the treatment of acute graft versus host disease MELBOURNE, Australia and NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- [...]
BeiGene Announces Acceptance of a Supplemental New Drug Application in China for Tislelizumab in Urothelial Carcinoma
31/05/2019
CAMBRIDGE, Mass. and BEIJING, China, May 30, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
BeiGene Announces Acceptance of Supplemental Import Drug Application in China for ABRAXANE® in Metastatic Pancreatic Cancer
31/05/2019
CAMBRIDGE, Mass. and BEIJING, China, May 30, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Extendicare Announces Voting Results from the 2019 Annual and Special Meeting of Shareholders and Board Changes
31/05/2019
MARKHAM, Ontario, May 30, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual and special shareholders’ meeting held on May [...]
Revive Therapeutics Announces Results for the Three and Nine Months Ended March 31, 2019
31/05/2019
TORONTO, May 30, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) ("Revive" or the “Company”) , a specialty cannabis company focused on the research, development and [...]

Pages